AU2517995A - Immunogenic carcinoembryonic antigen and methods of use and production - Google Patents

Immunogenic carcinoembryonic antigen and methods of use and production

Info

Publication number
AU2517995A
AU2517995A AU25179/95A AU2517995A AU2517995A AU 2517995 A AU2517995 A AU 2517995A AU 25179/95 A AU25179/95 A AU 25179/95A AU 2517995 A AU2517995 A AU 2517995A AU 2517995 A AU2517995 A AU 2517995A
Authority
AU
Australia
Prior art keywords
immunogenic
production
methods
carcinoembryonic antigen
carcinoembryonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25179/95A
Inventor
Craig Hackett
Gale Smith
Franklin Volvovitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MICROGENESYS Inc
Original Assignee
MICROGENESYS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MICROGENESYS Inc filed Critical MICROGENESYS Inc
Publication of AU2517995A publication Critical patent/AU2517995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
    • C07K2319/91—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU25179/95A 1994-05-20 1995-05-19 Immunogenic carcinoembryonic antigen and methods of use and production Abandoned AU2517995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24698194A 1994-05-20 1994-05-20
US246981 1994-05-20
PCT/US1995/006373 WO1995032286A2 (en) 1994-05-20 1995-05-19 Immunogenic carcinoembryonic antigen and methods of use and production

Publications (1)

Publication Number Publication Date
AU2517995A true AU2517995A (en) 1995-12-18

Family

ID=22933026

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25179/95A Abandoned AU2517995A (en) 1994-05-20 1995-05-19 Immunogenic carcinoembryonic antigen and methods of use and production

Country Status (2)

Country Link
AU (1) AU2517995A (en)
WO (1) WO1995032286A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2374894B1 (en) * 1993-09-13 2014-09-17 Protein Sciences Corporation A method for producing influenza hemagglutinin multivalent vaccines
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
ES2300419T3 (en) * 1995-05-26 2008-06-16 Protein Sciences Corporation METHOD FOR PRODUCING HUMAGLUTININE BASED ANTIGRIPAL VACCINES.
JP2001515361A (en) * 1997-05-06 2001-09-18 ザイモジェネティクス，インコーポレイティド Novel tumor antigen
CA2383562A1 (en) * 1999-08-26 2001-03-01 Keith M. Skubitz Peptides capable of modulating the function of cd66 (ceacam) family members
US6949629B2 (en) 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins
WO2004092216A1 (en) * 2003-04-15 2004-10-28 Trangene S.A. Carcinoembryonic antigen (cea) lacking a signal peptide, nucleic acid encoding it and fusion of cea with a t cell epitope and their use for the treatment and/or prophylaxis of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116640A1 (en) * 1993-03-25 1994-09-26 Alexey Terskikh Carcinoembryonic antigen derivatives

Also Published As

Publication number Publication date
WO1995032286A2 (en) 1995-11-30
WO1995032286A3 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
AU4518196A (en) Adjuvant-incorporated cellular antigens: conjugation and methods
AU3948295A (en) Joint structure and method of manufacture
EP0749731A3 (en) Coupling device and method of use
AU2071097A (en) Cannula and method of manufacture and use
AU6095696A (en) Immunogenic peptides of prostate specific antigen
AU1326895A (en) Methods of making and using ultrasonic handpiece
AU3091897A (en) Surf-or-sail-board and method of producing the same
ZA9810130B (en) Tumor-specific antigens methods for their production and their use for imunization and diagnosis
AU2579297A (en) Tunnelling device and method of producing a tunnelling device
AUPO056296A0 (en) Bag and method of production
AU1021997A (en) Cd100 antigen and uses therefor
AU2582195A (en) Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
AU5641798A (en) Artificial antibodies, method of producing the same and use thereof
AU6695398A (en) Immunoadhesins and methods of production and use thereof
AU4193496A (en) Process for the preparation of microspheres and microspheres made thereby
AU2517995A (en) Immunogenic carcinoembryonic antigen and methods of use and production
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
AU7245296A (en) Mhc-class ii restricted melanoma antigens and their use in therapeutic methods
AU3118297A (en) Sok-1 and methods of use
AU7168098A (en) Decorative bag making apparatus and method of use
AUPM482694A0 (en) Continuous mouldings and methods of production thereof
AU4505996A (en) 7-vinylidene cephalosporins and methods of using the same
AU5014896A (en) Antibody to human betacellulin and use thereof
GB2320370B (en) Coupled line and method of producing the same
AU697037B2 (en) Ethylamido fluorenes and improved method of making same